Volunteer Bias in Recruitment, Retention, and Blood Sample Donation in a Randomised Controlled Trial Involving Mothers and Their Children at Six Months and Two Years: A Longitudinal Analysis by Sue, Jordan et al.
 Cronfa -  Swansea University Open Access Repository
   
_____________________________________________________________
   
This is an author produced version of a paper published in :
PLoS ONE
                               
   
Cronfa URL for this paper:
http://cronfa.swan.ac.uk/Record/cronfa15457
_____________________________________________________________
 
Paper:
Hills, R., Jordan, S., Watkins, A., Storey, M., Allen, S., Brooks, C., Garaiova, I., Heaven, M., Jones, R., Plummer, S.,
Russell, I., Thornton, C. & Morgan, G. (2013).  Volunteer Bias in Recruitment, Retention, and Blood Sample Donation
in a Randomised Controlled Trial Involving Mothers and Their Children at Six Months and Two Years: A Longitudinal
Analysis. PLoS ONE, 8(7)
http://dx.doi.org/10.1371/journal.pone.0067912
 
 
 
 
 
 
 
 
_____________________________________________________________
  
This article is brought to you by Swansea University. Any person downloading material is agreeing to abide by the
terms of the repository licence. Authors are personally responsible for adhering to publisher restrictions or conditions.
When uploading content they are required to comply with their publisher agreement and the SHERPA RoMEO
database to judge whether or not it is copyright safe to add this version of the paper to this repository. 
http://www.swansea.ac.uk/iss/researchsupport/cronfa-support/ 
 Volunteer Bias in Recruitment, Retention, and Blood
Sample Donation in a Randomised Controlled Trial
Involving Mothers and Their Children at Six Months and
Two Years: A Longitudinal Analysis
Sue Jordan1*, Alan Watkins2, Mel Storey2, Steven J. Allen2, Caroline J. Brooks2, Iveta Garaiova3,
Martin L. Heaven2, Ruth Jones2, Sue F. Plummer3, Ian T. Russell2, Catherine A. Thornton2,
Gareth Morgan2
1Department of Nursing, The College of Human and Health Sciences, Swansea University, Singleton Park, Swansea, Wales, United Kingdom, 2 The College of Medicine,
Swansea University, Singleton Park, Swansea, Wales, UK Wales, United Kingdom, 3Obsidian Research Limited, Baglan Industrial Park, Port Talbot, West Glamorgan, Wales,
United Kingdom
Abstract
Background: The vulnerability of clinical trials to volunteer bias is under-reported. Volunteer bias is systematic error due to
differences between those who choose to participate in studies and those who do not.
Methods and Results: This paper extends the applications of the concept of volunteer bias by using data from a trial of
probiotic supplementation for childhood atopy in healthy dyads to explore 1) differences between a) trial participants and
aggregated data from publicly available databases b) participants and non-participants as the trial progressed 2) impact on
trial findings of weighting data according to deprivation (Townsend) fifths in the sample and target populations. 1) a)
Recruits (n = 454) were less deprived than the target population, matched for area of residence and delivery dates (n = 6,893)
(mean [SD] deprivation scores 0.09[4.21] and 0.79[4.08], t = 3.44, df = 511, p,0.001). b) i)As the trial progressed,
representation of the most deprived decreased. These participants and smokers were less likely to be retained at 6 months
(n = 430[95%]) (OR 0.29,0.13–0.67 and 0.20,0.09–0.46), and 2 years (n = 380[84%]) (aOR 0.68,0.50–0.93 and 0.55,0.28–1.09),
and consent to infant blood sample donation (n = 220[48%]) (aOR 0.72,0.57–0.92 and 0.43,0.22–0.83). ii)Mothers interested
in probiotics or research or reporting infants’ adverse events or rashes were more likely to attend research clinics and
consent to skin-prick testing. Mothers participating to help children were more likely to consent to infant blood sample
donation. 2) In one trial outcome, atopic eczema, the intervention had a positive effect only in the over-represented, least
deprived group. Here, data weighting attenuated risk reduction from 6.9%(0.9–13.1%) to 4.6%(21.4–+10.5%), and OR from
0.40(0.18–0.91) to 0.56(0.26–1.21). Other findings were unchanged.
Conclusions: Potential for volunteer bias intensified during the trial, due to non-participation of the most deprived and
smokers. However, these were not the only predictors of non-participation. Data weighting quantified volunteer bias and
modified one important trial outcome.
Trial Registration: This randomised, double blind, parallel group, placebo controlled trial is registered with the International
Standard Randomised Controlled Trials Register, Number (ISRCTN) 26287422. Registered title: Probiotics in the prevention of
atopy in infants and children.
Citation: Jordan S, Watkins A, Storey M, Allen SJ, Brooks CJ, et al. (2013) Volunteer Bias in Recruitment, Retention, and Blood Sample Donation in a Randomised
Controlled Trial Involving Mothers and Their Children at Six Months and Two Years: A Longitudinal Analysis. PLoS ONE 8(7): e67912. doi:10.1371/
journal.pone.0067912
Editor: Robert K. Hills, Cardiff University, United Kingdom
Received December 21, 2012; Accepted May 22, 2013; Published July 9, 2013
Copyright:  2013 Jordan et al. This is an open-access article distributed under the terms of the Creative Commons Attribution License, which permits
unrestricted use, distribution, and reproduction in any medium, provided the original author and source are credited.
Funding: The project was supported by the Knowledge Exploitation Fund, Collaborative Industrial Research (project number HE09 COL 1002), Welsh
Development Agency, United Kingdom (UK) and Cultech Limited, Unit 3, Christchurch Rd, Baglan Industrial Park, Port Talbot, SA12 7BZ, UK. Cultech Ltd. UK part
funded the trial and provided the probiotic and matching placebo, and generated the random allocation sequence. Sue Plummer is a Director of Cultech and
advised on study design and contributed to the final report. The sponsors were not involved in data collection, analysis or interpretation of the findings. The
Knowledge Exploitation Fund had no involvement in the conduct of the trial. The funders had no role in data collection and analysis, decision to publish, or
preparation of the manuscript. Dr. Sue Plummer proposed the product to be researched and commented on the study design. Dr. Sue Plummer and Dr. Iveta
Garaiova commented on the manuscript prepared by Sue Jordan to ensure clarity. No changes to the findings were either suggested or made.
Competing Interests: S. Jordan, S. J. Allen, C. A. Thornton, A. Watkins, R. Jones, I. Russell, C. J. Brooks, M. L. Heaven, and G. Morgan declare no conflicts of
interest. M. Storey received financial support from Cultech Ltd. I. Garaiova is a Senior Research Manager and S. F. Plummer is the Managing Director, Obsidian
Research Ltd. The affiliations of two authors and the commercial funding, along with any other relevant declarations relating to employment, products in
development does not alter the authors’ adherence to all the PLOS ONE policies on sharing data and materials, as detailed in the online guide for authors. The
product in the trial was not commercially available at the time of the trial.
* E-mail: s.e.jordan@swansea.ac.uk
PLOS ONE | www.plosone.org 1 July 2013 | Volume 8 | Issue 7 | e67912
Introduction
Recruitment to trials is deteriorating, particularly in developed
countries [1]: industry sources suggest that recruitment rates across
all trials fell by 75% between 1999–2002 and 2003–2006 [2].
Similarly, the proportion of recruits withdrawing from trials
steadily increased between 1955 and 2000 [3], prompting the US
Food and Drug Administration (FDA) to insist on measures to
minimise missing data and the consequent bias [4].
Bias arising within trials, due to systematic differences between
trial arms, threatens internal validity [5]. In addition, the external
validity, generalisability, transferability and utility of well-conduct-
ed trials may be threatened where recruited and retained samples
are less than 100% of the target population. Such selection bias,
defined as the introduction of error due to systematic differences in
the characteristics between those selected and those not selected
for a given study [6], renders the recruited sample unrepresenta-
tive of the target population [7–9].
Recruitment of volunteers is a potential source of selection bias
[10]. Where a sample can contain only those willing to participate
in the study or experiment, systematic differences may arise
between those who volunteer and those who decline or do not
respond to invitations. Such ‘‘volunteer bias’’ is defined as any
process at any stage of inference which tends to produce results or
conclusions that differ systematically from the truth, arising where
volunteers from a specified sample may exhibit exposures or
outcomes which differ from those of non-volunteers [11].
Volunteer bias may arise during recruitment, retention, partici-
pation in follow-up clinics [12], and consent to blood sample
donation. Volunteers may differ from the target population not
only in socio-demographic characteristics, but also in less tangible
ways, such as perceptions of the study’s leverage, saliency or
relevance [13], or altruism [14].
The antithesis of volunteer bias, non-response bias [11], has
been well scrutinised in surveys [13,15] and observational studies
requiring consent [16]. Although trials suffer higher non-response
rates than surveys or observational studies [17–19], analysis of trial
data rarely accounts for volunteer bias [7,20]. Searches of three
databases (PubMed, Web of Science, Scopus) located no reports of
predictors of participation and consent to sample donation by well
infants in clinical trials, using the key word/MeSH term
combination: randomised controlled trials, pregnant women,
infants, preventive therapy, research subject recruitment, loss to
follow up, non-response bias, with or without ‘‘blood specimen
collection’’.
Little is known about families who decline to participate in
clinical trials [21]. While there are exceptions, such as parents of
seriously ill children [14], and situations where research offers the
only access to free medication [22], non-targeted recruitment in all
research designs favours healthier, wealthier, better educated, non-
smokers, risking volunteer bias [10,12,17–19,23–27]. The poten-
tial consequences of volunteer bias might be summarised [28]:
N Volunteer bias threatens the generalisability or external
validity, transferability, and utility of findings and detracts
from their clinical value [20]. When ‘hard to reach’ sections of
the population are not included in a study, there can be no
certainty that findings will be applicable to them. If a trial has
been conducted in a population judged to be over-restricted,
dissimilar or unrepresentative, findings may be dismissed as
irrelevant. Prevention or vaccine trials are particularly
vulnerable to such criticisms [7,19,26,29–33].
N The incidence of disease in the recruited sample may be lower
than accounted for in sample size calculations based on the
incidence of disease in the whole population. This could leave
the trial under-powered even when the target sample size
has been recruited.
N Where trials report on conditions whose prevalence varies
across the socio-demographic spectrum, findings, particularly
estimates of the absolute effects of interventions (such as
numbers needed to treat or harm, and costs), are often affected
by over- or under-representation or exclusion of certain groups
[7].
Evidence on which to base practice recommendations for wide
sections of the population requires ‘Research evidence reflecting
the diversity of the population’ [34], and trials with minimal
demographic imbalance in recruitment and retention [28]. This
paper aims to extend the application of the concept of volunteer
bias to clinical trials, using data from a paediatric trial, by
exploring:
1. Potential for Volunteer Bias
a) Differences between the recruited sample and the target
population.
b) Impact on retention, clinic attendance, consent to skin-prick
testing and blood sample donation by well infants of i)
demographics ii) leverage, saliency and altruism.
2. Adjustment for potential volunteer bias by weighting
outcome data [8] according to material deprivation (Town-
send) fifths.
Methods
Ethics Statements
N Ethical approval was granted in February 2004 by the South
West Wales Research Ethics Committee on behalf of NHS
Wales (project ref. 2004.024). Women were given written
information on the trial and data collection, and gave
informed, signed consent at 36 weeks’ gestation.
N Data held in SAIL databases are anonymised and aggregated
and have been obtained with permission of relevant Data
Protection Officers, as approved by the National Research
Ethics Service, Wales [47,48].
The Trial
As reported elsewhere [35,36], this randomised, double-blind,
placebo-controlled, parallel-group trial assessed the effects of
probiotic food supplements on key immune parameters and
prevention of atopy and atopic conditions (asthma, eczema and
allergic rhinitis) in young children. Healthy women with normal
singleton pregnancies under the care of clinicians in Abertawe Bro
Morgannwg University Health Board, Wales, UK were recruited
May 2005- October 2007. All participants were ambulatory,
managed in primary care, and well or ‘‘free from disease’’ at
recruitment, although many infants were at high or increased risk
of developing atopic conditions. Inclusion criteria were: mother
aged $16 years, normal singleton pregnancy, gestation at delivery
.36 weeks, freely given, signed, informed consent to participate in
the study. We excluded: women unable or unwilling to give
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informed consent, those with any serious medical condition
affecting the woman or infant or the likely outcome of the
pregnancy, families where a member of the infant’s sibship or
household was already recruited to the study. Women were asked
to take the probiotic supplement daily from recruitment at 36
weeks until delivery, and administer the supplement to their
infants daily from birth to age 6 months.
Sample Size
A sample of 308 infants (154 in each group) was sufficient to
detect a 50% reduction in eczema frequency (40% to 20%) in the
probiotic group [37] with 90% power and 1% significance. To
demonstrate a similar proportional reduction in asthma at 5 years
(20% to 10%) [38], 538 infants would have been required. We
recruited 454 pregnant women within available resources.
Recruitment Strategy
A multifaceted recruitment strategy was designed to contact the
whole population of pregnant women in the catchment area
(Table 1). Most (362, 79.7%) participants were recruited by one of
seven fieldworkers, minimising the impact of the approach style of
individual researchers. Written information indicated that the trial
was focussed on prevention of eczema and asthma in infants and
children, who were at either increased or normal risk of developing
atopy. The risk factor considered was one or more family member
already suffering from an atopic condition (asthma, eczema or
allergic rhinitis).
Research Clinics
When infants reached 6 months and 2 years of age, carers were
invited to research clinics. Participants were informed at recruit-
ment and reminded at invitation that separate signed, informed
consent would be sought for skin-prick testing for common
allergens (housemite, grass, cow’s milk, egg, cat) and, at 6 months
only, for blood sample collection from the infant for immunolog-
ical investigation. Interpretations of skin-prick testing were offered
to carers immediately and could be used to modify exposure to
common allergens. To minimise attrition, considerable efforts
were made to contact participants, and where infants were unable
to attend clinics, information was obtained by home visits or
telephone interviews [39].
Data Collection
Trial data were obtained from several sources:
1. Questionnaires (covering demographics, compliance, risk
factors for atopy, signs and symptoms of atopic conditions,
adverse events [40] and infant’s health) at: 36 weeks of
Table 1. Recruitment strategies considered.
Strategy Used Advantages Disadvantages Findings
Non-targeted
Written information distributed
by a) midwives to all women
attending booking clinics in
primary care from 12 weeks’
gestation b) receptionists to all
women attending hospital for
routine 20 week ultrasound scan
Yes Maximum coverage of
population of pregnant
women. (We estimate
that .99% women in
our area book for
(free) antenatal care.)
Not labour intensive.
Risks non-contact bias by
failing to contact those not
booking, typically the most
disadvantaged. Assumes
literacy. Information is not
tailored to individuals’ needs,
health beliefs or world views.
Relies on health service staff.
Recruitment [13,90], and retention [91] demanded a
labour-intensive face to face approach. Written
information alone was insufficient [92]: only
36/454 (7.9%) participants were recruited without
a personal approach. These participants were less
likely to emanate from deprived areas (U = 5627,
Z =22.05, p = 0.04, effect size, r = 0.09). Although
written information was widely distributed, most
(69%, 286) recruits did not recall receiving it.
Media: website, TV, local
press and radio
Yes Reaches a wide
audience amongst the
‘less ill’, including
partners and families
[93,94], who may
influence women’s
decision-making.
Advertising costs. Impact
may be disappointing [75],
and difficult to quantify.
We observed little impact. Following TV coverage,
we received five telephone calls, all from women
living outside the catchment area or already delivered.
Two (0.5%) recruits first heard of the trial on TV and
7 (1.7%) via radio. We do not know whether the media
had any more subtle effects in preparing families for
researchers’ approaches.
Monetary incentives No The most effective
strategy to improve
recruitment. A ‘dose-
response’ effect is
suggested [95–97].
Not recommended for
research involving children
in the UK [98:90].
We offered no inducements, and no-one mentioned ‘Getting
things for free’ [90]. Rather, 90% (372/413) participants agreed
that ‘research is everyone’s business’ [99]. There was general
recognition that research could only happen and medical
management could only improve if families were willing to join
trials.
Targeted
Personal approach in
hospital antenatal clinics.
Yes A personal approach
tailors presentation
of the trial to each
individual’s health
beliefs, world views or
need for information
[60,100].
Insufficient resources
to speak with all women.
Labour intensive and therefore
costly. Risks non-contact bias
by excluding those not
attending, typically the most
disadvantaged.
A personal approach improved the socio-demographic
representation of the recruited sample by allowing researchers
to tailor presentation of the trial to each individuals’ need for
information [60,100], which resonates with leverage-saliency
theories of participation and marketing techniques
[74,76,101,102].
Personal approach in
community groups
(in this study, parenting
and aquanatal classes).
Yes In the USA, involvement
in community groups, at
church or civic events,
increased recruitment of
women from ethnic
minorities [103].
Some classes are poorly
attended. Labour intensive,
often outside office hours.
Only 20/454 (4.4%) women were recruited this way. Their
deprivation scores were not significantly different from the
whole sample. The effectiveness of this recruitment strategy is
likely to be context specific.
doi:10.1371/journal.pone.0067912.t001
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pregnancy (recruitment), 6, 12, 18 weeks, 6 months, 1 and 2
years. At the 6 month contact, researchers asked five questions
to elicit parents’ reasons for joining the trial, and their views on
the trial. Responses to open questions were recorded for
illustration.
2. Medical records: maternity and child health.
3. Biological Samples: maternal blood at 36 weeks’ gestation,
infant blood from the umbilical cord and venepuncture at 6
months, placental tissue, breast milk at 2 and 6 weeks, stool
samples at birth, 2, 6, 12, 18 weeks and 6 months.
4. Procedures: clinical examination and skin-prick tests for
common allergens at 6 months and 2 years.
No information was available on non-respondents, so summary
statistics relating to the target population were obtained for
comparison [41] from all publically available sources:
1. 2001 Census [42] for occupation, ethnicity, and household
status. Parents’ most recent occupations were coded and
grouped in accordance with Office of National Statistics (ONS)
[42–44];
2. Infant Feeding Survey [45] for smoking and alcohol use;
3. Welsh Health Survey [46] for asthma;
4. All-Wales health services’ electronic database (Secure Anon-
ymised Information Linkage [SAIL] database) [47,48] for
material deprivation, as Townsend scores, ranks and fifths.
Townsend scores are calculated from rates of unemployment,
vehicle ownership, home ownership, and overcrowding for
each geographical area of residence, using Lower Super
Output Areas (LSOAs) defined by postcodes. [49]. We
generated a comparator group within SAIL defined by:
a. precise geographical area of residence at birth, using LSOAs.
b. births during the recruitment period (May 2005 to November
2007).
Data were entered into IBM SPSS statistics v19 for Windows, in
duplicate. Files were compared electronically (SPSS Data Entry
Builder v4) and discrepancies reconciled before analysis.
Analysis
1) a) The recruited sample was compared with external
population data, listed above.
b) Retention, clinic attendance, consent to skin-prick testing
for allergy, retention at 6 months and 2 years, and blood
sample donation were explored in bivariate analyses, and,
where feasible, by logistic regression [50], with variables as
listed (Tables S1, S2). Regression models were built iteratively
using i) socio-demographic variables ii) variables reflecting
leverage, such as rashes, and reasons for joining the trial, such
as altruism. Model parameters for each stage were compared.
We checked for any attrition bias linked to trial arm.
2) Further analyses of the trial outcomes were undertaken to
explore the potential impact of volunteer bias, as recom-
mended [4]. Trial outcome data were weighted to reflect the
distribution of deprivation (Townsend) fifths amongst respon-
dents for each outcome relative to the target population
matched in the SAIL database. The weighting factor for each
fifth was calculated as that fifth’s proportion in the population
divided by the proportion in the sample for each outcome
(weighting factor =% in population/% in sample). SPSS
statistics then created a new frequency variable by multiplying
existing frequencies by the weighting factor. Associations
between trial arm and clinical outcome were re-tested.
Subgroups were used solely to explore the findings.
Results
Between April 2005 and June 2007, 1419 expressions of interest
were received, yielding 454 recruits (32%, 454/1419). Over the
2.25 years of recruitment, this 1419 represents almost 2% of the
,74,000 births in Wales, and 20% of the 6,893 women delivering
in the LSOAs represented in the trial as identified in the SAIL
database. Attrition was 5.3% (24/454) at 6 month contact
(Figure 1) and 16.3% (74/454) at 2 years (Figure 2).
1) Potential for Volunteer Bias
a) Recruitment. The recruited sample was less materially
deprived than the target population closely matched for area of
residence at birth (Table 2). A disproportionate number of recruits
were from the least deprived (Townsend) fifth. Occupational
group distributions differed between trial participants and the
population of South West Wales in the 2001 Census [42] (Tables
S3, S4). Both these differences intensified as the trial progressed
(Figures 3, 4).
Census data [42] indicated that ethnic minorities were not
under-represented. We recruited relatively few lone parents (19,
4.2%), when compared with households containing children of all
ages in South West Wales (7.53%). No-one was classified as
‘homeless’ at recruitment. Comparisons with pregnant women in
Wales suggest that the recruited sample may over-represent non-
smokers (Figure 5) and alcohol abstainers [45] (Table 2).
Most, 69% (286/417 responding to the question) participants
reported first hearing about the trial when they were approached
by researchers in antenatal clinics. This personal approach was
crucial to the decision to enrol for most participants (233/404
responding, 58%). The hope of preventing asthma or eczema in
their infant was parents’ most frequently cited reason for joining,
followed by interest in eczema, asthma or allergy (Table S2).
Altruistic motives were also apparent: 47% (190/403) stated that
helping research and 42% (166/398) that helping children were
important motivators, as illustrated:
Anything to help prevent the children of the next generation developing
allergies. (Participant 147, full participation).
But these considerations could be over-ridden:
I wanted to help find a cure for eczema, but my family said we were being
used as ‘guinea pigs’, so I stopped. (participant 118, telephone follow up).
Of reasons for joining the trial considered (Table S2), only
‘interest in probiotics’ was associated with occupational group (x2
8.55, p = 0.003, df = 1) or deprivation (Townsend) fifth (x2 4.27,
p = 0.04, df = 1).
b) Retention. Internal comparisons indicated that the most
disadvantaged were less likely to be retained at 6 months.
Comparisons using ONS categories and deprivation (Townsend)
fifths gave similar findings: 17/24 (70.8%) lost came from ONS
category 3 (routine occupations and unemployed) compared with
149 of 449 (33.2%) recruited (x2 14.46 df = 1, OR 0.19, 0.08–
0.46, p,0.001); 13/24 (54.2%) were from the most materially
deprived fifth compared with 123/454 (27.1%) recruited (x2 8.01,
df = 1, OR 0.29, 0.13–0.67, p= 0.01) (Figure 6, Table S1).
Attrition was higher amongst smokers (x2 14.38, df = 1, OR
0.20, 0.09–0.46, p,0.001). Five of the 19 (26.3%) single mothers
were lost to follow up. At 2 years, in multivariate analysis,
retention at 2 years was associated with maternal age, not smoking
Volunteer Bias in Randomised Controlled Trials
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at recruitment, occupation category, carers’ reports of rashes and
reporting any adverse events during supplementation (Table 3).
Clinic Attendance and consent to skin-prick testing were
necessarily closely linked. Demographic variables predicted clinic
attendance and consent to testing at 6 months and 2 years (Table 3,
Figures 3, 4, 5). Only the most disadvantaged categories
(deprivation (Townsend) fifth and ONS category 3, routine
occupations or never worked) were associated with non-atten-
dance and declining testing. Logistic regression model parameters
improved when putative motivations for clinic attendance or
leverage, such as reports of rashes or adverse events, and reasons
for joining the trial relating to saliency and altruism, such as
‘interest in probiotics’, were taken into consideration (Table 4).
‘Wanting to help research’, predicted involvement at 6 months,
but not at 2 years (Table 3).
Consent to venous blood sample donation by infants at 6
months was positively associated with professional or managerial
occupations, not smoking, being in the intervention arm, interest
in the trial intervention, wanting to help children and be involved
in research, and experiencing asthma in adulthood. It was
negatively associated with maternal use of corticosteroids
(Table 3). Including factors related to reasons for joining the trial
reflecting altruism, such as ‘wanting to help children’, strength-
ened the regression outputs. However, infants’ rashes and adverse
events were not associated with consent (Table 4).
2) Data Weighting to Assess Volunteer Bias
Weighting the data according to the distribution of material
deprivation (Townsend) fifths relative to the SAIL database (Table
S5) changed some trial findings, but not others (Table 5). Post hoc
Figure 1. Participant Flow Diagram for observation study to 6 month contact point.
doi:10.1371/journal.pone.0067912.g001
Figure 2. Participant Flow Diagram for observation study to 2 year contact point.
doi:10.1371/journal.pone.0067912.g002
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subgroup analyses of deprivation (Townsend) fifths indicated that
findings were unchanged where the impact of the intervention was
concentrated in the under-represented group, the most deprived
(atopic sensitisation). However, findings were modified where
impact of the intervention was concentrated in the over-
represented group, the least deprived (atopic eczema). The
absolute risk reduction was changed by 36.2%, from 6.9% (0.9–
13.1%) to 4.6% (21.4–10.5%), and the odds ratio by 40%, from
0.40 (0.18–0.91) to 0.56 (0.26–1.21) (Table 5). Doctor-diagnosed
eczema appeared to be more common in the least deprived
participants, and asthma in the most deprived, but differences
were not statistically significant. Interaction terms between
treatment arm and material deprivation (as Townsend fifths) were
not significant.
Discussion
Potential for volunteer bias, created at recruitment, intensified
throughout the trial (Figures 3, 4, 5). Retention and participation
were associated with socio-demographic variables, smoking status
and variables reflecting leverage, saliency and altruism. Trial
findings were modified by data weighting to account for volunteer
bias (Table 5).
Limitations and Strengths
From single site research, we cannot assume that respon-
dents and response patterns are representative of other popula-
tions. Unusually for a clinical trial [51], the lead institutions are in
an area of the European Union (EU) where GDP is 75% below the
community average, a Convergence area [52]. Trial location may
have influenced recruitment, retention, and sample donation. For
example, attitudes towards blood donation differ between com-
munities [53–55].
This trial was restricted to healthy dyads. To our
knowledge, predictors of carers’ consent to blood sample donation
by well infants have not been explored in other trials, and
associations reported here require testing in other populations
[50]. However, cohort studies report similar clinic attendance rates
[56]. The balance between benefit and harm is more uncertain in
prevention or vaccine trials involving healthy participants than in
therapeutic trials [57]. Further work is needed to explore
generalisation of these findings to trials involving unwell or
hospitalised children, where recruitment is restricted to closely
defined populations with current medical conditions [14,58–60].
Comparison with external data was the only option
available to evaluate demographic representation at recruitment;
however, some ages, locations and time-frames were not entirely
congruent. Therefore, we tested this approach by comparing the
deprivation scores and rankings of respondents with those of
women giving birth in the same timeframe and geographical areas.
We are unaware of other trials testing sample selection using this
approach. The similarity between the comparisons indicates that it
would be reasonable to assess volunteer bias using Census data
where closely matched population data is unavailable.
The data sources used for comparison are themselves vulnerable
to social desirability, volunteer and non-response bias, and may
not be fully representative of the population. For example, the
Table 2. Comparisons between the recruited sample and external data.
Source of comparison data Trial data Comparator data Test
Mean [SD] Mean [SD] t test5 significance, effect size
Deprivation scores1:
whole sample, 454
All-Wales health services’
electronic database, SAIL
(n = 6,893)
0.09 [4.21] 0.79 [4.08] 3.44, df 511 p,0.001, r 0.15
Deprivation rank1 for
Wales: whole sample, 454
All-Wales health services’
electronic database, SAIL
925.58 [624.10] 1037.60 [591.3] 3.74, df 495 p,0.001, r 0.17
Number (%) Number (%) x2 (df 1) OR, 95% CI
Deprivation: least
deprived fifth1
All-Wales health services’
electronic database, SAIL
136/454 (30%) 1,327/6,893 (19.3%) 29.9 1.79, 1.45–2.21
Women from ONS 3 (routine
occupation or never worked) 2,3
2001 Census, South
West Wales [42]
149/454 (32.8%) 43,474/98,136 (44.3%) 24.14 0.61, 0.50–0.75
Asthma as an adult:
women2
Welsh Health Survey
2007 [46] women 16–44
104/454 (23%) 291/2,908 (10%) 61.79 2.67, 2.08–3.43
Asthma as an adult: men3 Welsh Health Survey
2007 [46] Men 16–44
83/441 (19%) 203/2,541 (8%) 49.61 2.67, 2.02–3.53
Women of non-white
ethnic origin4
2001 Census, South
West Wales [42]
15/398 (3.8%) 8,304/503,256 (1.65%) 9.72 2.33, 1.39–3.91
Women smoking2 Infant feeding survey, pregnant
women in Wales 2005 [45]
73/454 (16%) 457/2,076 (22%) 7.57 0.68, 0.52–0.89
Women: alcohol
intake, any2
Infant feeding survey, pregnant
women in Wales 2005 [45]
193/453 (43%) 1,141/2,085 (55%) 21.44 0.61, 0.50–0.75
Notes to table: No correction taken for multiple comparisons.
1Deprivation (Townsend) scores, ranks and fifths are based on geographical area of residence, using Lower Super Output Areas (LSOAs) defined by postcodes. This
measure of material deprivation is calculated from rates of unemployment, vehicle ownership, home ownership, and overcrowding [49].
2In five cases, both parents were students, and ONS categories could not be allocated. Fathers’ occupations taken where no occupation for mother [44,49].
3as reported by mothers at recruitment at 36 weeks’ pregnancy.
4as in hospital records.
5unequal sample sizes, unequal variances.
doi:10.1371/journal.pone.0067912.t002
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2001 Census had a 93–94% response rate in Wales, falling below
90% for women aged 20–24 [61]: the most disadvantaged are
likely to be under-represented [62]. Accordingly, our calculations
may underestimate demographic imbalance. Reports of behaviour
are vulnerable to social desirability response biases, but we
Figure 3. Proportion in each deprivation (Townsend) fifth in the population and each stage of the trial.
doi:10.1371/journal.pone.0067912.g003
Figure 4. Proportion of participants from ONS Category 3 at each stage of the trial.
doi:10.1371/journal.pone.0067912.g004
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have no reason to assume that our data would be uniquely
vulnerable.
Non-contact bias should be distinguished from volunteer bias
[13]. The recruited sample’s composition may have been
influenced by the characteristics of women attending ante-natal
clinics and community groups. Marginalised women may not
access care or only accept domiciliary care in refuges, so would
neither have received our invitation letters nor been approached
(Table 1).
Interpretation of weighted analyses rests with readers; this
strategy to account for volunteer or non-response bias is routine in
observation studies, including UK birth cohorts [25,63–65]. We
acknowledge the limitations of post hoc subgroup analyses [66,67],
and present these solely to illustrate how outcome distribution
affects data weighting, not to guide clinical practice. Low numbers
in outcome variables necessitate cautious interpretation; however,
these findings merit exploration in pooled data sets and meta-
analysis.
Figure 5. Comparison of proportion of smokers at each stage of the trial.
doi:10.1371/journal.pone.0067912.g005
Figure 6. Women lost to follow up at 6 months compared with the whole sample.
doi:10.1371/journal.pone.0067912.g006
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1. Potential for Volunteer Bias
a) Recruitment strategies in this trial favoured wealthier
families with healthier behaviours, as in observation studies
[17–19,23–25], cluster [26] and adult prevention trials
[10,12,27]. Significant degrees of sub-optimal recruitment
and potential volunteer bias are relatively recent phenomena
[68,69]. Just as recruitment to trials is becoming increasingly
difficult [2], successive UK birth cohorts have had lower
response rates. While the 1958 & 1970 MRC cohorts
recruited 98.76% & 95.86% (17416/17634 & 16571/
17287) of those approached [70,71], the Millenium Cohort
had a 68% unweighted response rate (72% in Wales) [25].
b) Retention was influenced by socio-demographic and less
tangible factors.
i) The most disadvantaged and smokers were less likely to
participate in follow-up, attend clinics, consent to skin-prick
testing or blood sample donation. Treatment allocation had
no negative impact.
N ii) Potential for volunteer bias in the retained samples was not
confined to socio-demographic parameters [72,73]. Multi-
variate analyses indicated that when demographics were
accounted, leverage, saliency [13,74] and altruism [14,75]
are important predictors of participation (Table 4). To our
knowledge, this has not been tested in trial data.
The saliency and leverage of the trial, clinic or skin-prick
testing, and the theory of social exchange [74,76,77] featured in
binary, threshold decisions to participate. Opportunities to see
consultant paediatricians and receive allergen testing may have
been particularly attractive to carers of infants experiencing
adverse events or rashes. Access to treatment [22] or expectation
of better attention incentivise participation [59,78].
Altruism was important in the decision to consent to venous
blood sample donation by well infants. Here, there were no
possible direct benefits to the family, and the infant’s discomfort
was a deterrent [79]. Leverage related to clinic attendance and
skin-prick testing was discounted, and ‘wanting to help children’
predicted consent. Requests for time and biological samples deter
many potential trial participants [1,17,30,80,81]. However, 220
participants consented to sample donation. Such altruism is more
evident in less recent trials [75].
2. Volunteer Bias in Trials and Data Weighting
Applying the concept of volunteer bias to trial data tests the
generalisability, external validity, transferability, utility and
dependability of trial findings. Keyword searches in three
databases (PubMed, Web of Science, Scopus) indicate that data
weighting to account for and quantify potential volunteer bias is
rarely undertaken in paediatric prevention trials.
Generalising the Findings
Findings (Table 5) suggest that to minimise any risk that results
may be distorted by systematic differences between participants
and the population likely to use the trial’s findings, outcomes
should be assessed in samples as free of volunteer bias as possible
[7,26]. Although an unrepresentative sample does not necessarily
mean that findings would not be replicated in a wider population,
research quality criteria include non-biased sample selection [82].
This is particularly important where participants’ characteristics
influence study outcomes [8,13,19,32,83]. Strategies to account for
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missing data, such as sensitivity analysis, do not address volunteer
bias [84]. It cannot be assumed that participation and attrition are
random events, prompting calls for full details of target or eligible
populations to be reported for all trials [20].
Power of the Trial: Recruiting the Target Population
Problems were confined to the most materially disadvantaged
and smokers. Non-targeted recruitment and retention risk
volunteer bias and disenfranchisement of the least affluent and
most marginalised, where childhood ill-health is concentrated
[85]. Many outcomes in health services’ research, including
childhood asthma and wheezing, are affected by material
deprivation [16,85,86], or geographical location [87]. Eczema is
associated with urbanisation [88] and parents’ educational
attainment [89], both linked with reduced deprivation. Here,
doctor-diagnosed eczema was no less common in the over-
represented group (the affluent) (Table 5), indicating that volunteer
bias did not reduce the study’s power for this outcome. However,
asthma was less common in the over-represented group. For this
outcome, it will be important to consider any potential loss of
power, as the event rate proportion may differ between the
population and the recruited and retained samples.
Robust Trial Findings: Suggestions and Solutions
Weighting increased the leverage of data from the most
deprived participants (Table 5). Accordingly, this confirmed the
robustness of positive outcomes concentrated in under-represented
groups (atopic sensitisation). However, where the intervention’s
impact was concentrated in over-represented groups (atopic
eczema), weighting changed both the absolute and relative effects
of the intervention. Weighting techniques, standard practice in
cohort studies [25,63–65], based on demographic distribution at
recruitment, can augment analyses of trial data [8,41]. Such
weighting is based on assumptions that participants from
disadvantaged groups are representative or typical of their groups
in all respects, including attributes not recorded; only careful
fieldwork and local knowledge can support such suppositions.
Obviating any need for such subjective judgments, and obtaining
trial evidence on which to base practice recommendations to the
wider, target population, necessitates engagement, recruitment
and retention of fully representative samples [34,82]. Strategies
include:
N Additional resources. Trialists are under pressure to recruit to
safeguard their sponsors’ investments. However, the disadvan-
taged are disproportionately hard to reach [13,21]. To
safeguard investment in clinical trials, the research community
should budget sufficient time and resources for complicated,
personalised contact and follow up procedures [18,28], as in
birth cohorts [25,63].
N Stratification of the population and over-sampling those least
likely to participate, as in cohort studies [25,63–65].
N Electronic follow up using routinely collected health services’
data, where available. More work is needed to evaluate this
approach and assess the traceability of respondents.
N Weighted analysis to account for residual problems. Account-
ing for all possible confounders will be difficult, but even
partial mapping strengthens the analysis [41].
Conclusions
If trial evidence is to reflect population diversity, demograph-
ically representative samples should be recruited and retained.
Disproportionate socio-demographic representation arising at
recruitment intensified throughout the trial. Accounting for this
by data weighting to assess volunteer bias modified important trial
findings. Whether this would occur in other trials warrants
investigation. However, material deprivation is not the only
predictor of participation. The leverage-saliency theory of research
participation remains important; additionally, these findings
indicate that altruism should not be discounted. Application of
the concept of volunteer bias to clinical trials suggests that to offer
reassurance regarding the generalisability, external validity,
transferability, utility and dependability of findings, researchers
should quantify differences between recruited samples and target
populations and weight data to protect findings from potential
distortion by volunteer bias.
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